image_name stringlengths 68 68 | type stringclasses 2
values | gt_table stringlengths 116 12.6k |
|---|---|---|
be493fa4d39b0cf55486eaffcc09020162867fd938db2c2433163dc1d1d25a3a.png | simple | <table><tr><td>Partition</td><td>Resolution<sup>1</sup></td><td>TE MAFFT<sup>2</sup></td><td>TE BAli-Phy<sup>2</sup></td><td>Protein coding</td></tr><tr><td>rRNA MAFFT</td><td>95%</td><td>0.287</td><td>0.264</td><td>0.309</td></tr><tr><td>rRNA BAli-Phy</td><td>95%</td><td>0.272</td><td>0.221</td><td>0.261</td></tr><tr>... |
6320f4d036f8f47af1e345e1d356ac57fd83a0d3fd235723a6bf30933f2cdad7.png | simple | <table><tr><td>Variable</td><td>Carotid Score</td><td>m-IMT</td><td>Left Ventricular Mass</td></tr><tr><td>Age</td><td>r = 0.53p < 0.01</td><td>r = 0.46p < 0.01</td><td>-</td></tr><tr><td>Weight</td><td>-</td><td>-</td><td>r = 0.53p < 0.01</td></tr><tr><td>Height</td><td>-</td><td>-</td><td>r = 0.38p < 0.05... |
d74b60f0bc226aea809cd2a27ea3aa266c940c3d4d3952c424378643e19de0ae.png | simple | <table><tr><td></td><td>MCF-7</td><td>MDA-MB-231</td></tr><tr><td>SSTR1</td><td>++</td><td>+++</td></tr><tr><td>SSTR2</td><td>+++</td><td>++</td></tr><tr><td>SSTR3</td><td>+</td><td>+</td></tr><tr><td>SSTR4</td><td>++++</td><td>++++</td></tr><tr><td>SSTR5</td><td>+</td><td>+</td></tr></table> |
1dc7eec4c7b7a21fca810981df04035219392e4e8f1689a4673f904646c139e7.png | simple | <table><tr><td>Characteristic</td><td>Coefficient (95% CI)</td><td><i>p</i>-value</td></tr><tr><td>Treatment regimen</td><td></td><td>0.04</td></tr><tr><td> Prophylaxis</td><td>10.0 (0.7, 19.3)</td><td></td></tr><tr><td> On-demand</td><td>reference</td><td></td></tr><tr><td>Chronic pain<sup>b</sup></td><td></td><td>0.0... |
462ddc722405bc42bef7faabfb25dbce4341d95dc3cac7f2402363eb32a38fa6.png | simple | <table><tr><td>Subgroups</td><td>HR</td><td>95% CI</td><td><i>P</i> Value</td></tr><tr><td>Patients with diabetes mellitus</td><td>0.36</td><td>0.14 to 0.90</td><td>0.03</td></tr><tr><td>Patients without diabetes mellitus</td><td>0.74</td><td>0.41 to 1.33</td><td>0.32</td></tr><tr><td>Patients with hypertension</td><td... |
edc357e374654751ae0189a7f638a1c483bd7b662c3d1135146f6bc4adbef848.png | simple | <table><tr><td></td><td><i>baseline n (%)</i></td><td><i>six months n (%)</i></td></tr><tr><td>Nightly pain</td><td>75 (34.7%)</td><td>68 (31.5%)</td></tr><tr><td></td><td></td><td>(38 (50.7%) persistent)<sup>b</sup></td></tr><tr><td>Unbearable pain</td><td>29 (13.4%)</td><td>34 (15.7%)</td></tr><tr><td></td><td></td><... |
fa3b7b69c2adc38cf88134c231bff4b1aa6d5f35e560baae837ac9a1123a1696.png | simple | <table><tr><td>Assays<sup><i>b</i></sup></td><td>Sensitivity (%)</td><td>Specificity (%)</td><td>Accuracy (%)</td><td>LR+<sup><i>c</i></sup></td><td>LR−<sup><i>d</i></sup></td><td>DOR<sup><i>e</i></sup></td><td>ROC analysis, AUC (95% CI)</td></tr><tr><td>WB PCR<sup><i>f</i></sup> (95% CI)</td><td>73 (54–86)... |
a60470b8b17ce8aec5df4700cb9faa82781f7efcca03746635352fb555174cfb.png | simple | <table><tr><td></td><td>NSR (<i>n =</i> 361)</td><td>AF (<i>n =</i> 81)</td><td><i>p</i></td></tr><tr><td>Before surgery</td><td></td><td></td><td></td></tr><tr><td> LV end diastolic dimension (mm)</td><td>56.6 ± 10.8</td><td>55.0 ± 10.9</td><td>0.375</td></tr><tr><td> LV end systolic dimension (mm)</td><td>3... |
7c784c013f61449d0ef01178c253511a64ed46e3d54ac321aa2ac19b84c16dd7.png | simple | <table><tr><td> </td><td> </td></tr><tr><td>•</td><td>‘I would prefer to see the same consultant in hospital, as I trust her already and would find it hard to build the same level of trust with someone else’</td></tr><tr><td>•</td><td>‘Continuity of care- New consultant may not read all in... |
456e75af606352144ff156724151c0ca165298a96b922b4c117f0972cc5ea284.png | simple | <table><tr><td>Medium</td><td></td><td>Score</td></tr><tr><td>Ham's F-12</td><td>+10% FCS</td><td>180</td></tr><tr><td>DMEM/Ham's F-12 (1:1)</td><td>+10% FCS</td><td>170</td></tr><tr><td>Medium199</td><td>+10% FCS</td><td>165</td></tr><tr><td>DMEM</td><td>+10% FCS</td><td>165</td></tr><tr><td>McCoy's 5A</td><td>+10% FC... |
aecc24deaeaf216080a2bc52f64adcd2ee147818a91ce7e6e7262b974d386559.png | simple | <table><tr><td>Author, Year, Citation</td><td>Sample size*</td><td>Respondents who reported the PtDA was balanced.n (%)</td><td>Did the PtDA include side-by-side display of evidence?</td><td>Did the PtDA include any side-by-side display?</td></tr><tr><td>Mathieu, Barratt et al., 2010 [14]</td><td>117</td><td>66 (57%)</... |
088596795b3884bc7ea46a0611cef63c721996e7a98bb2f7bf2332c493141860.png | simple | <table><tr><td>Position of the tapes</td><td>at 3 months after surgery</td><td>at 6 months after surgery</td><td>at one year after surgery</td></tr><tr><td>Proximal third of the urethra</td><td>3,92 %</td><td>9,81 %</td><td>9,81 %</td></tr><tr><td>The middle third of the urethra</td><td>88,23 %</td><td>82,35 %</td><td>... |
cc913866ad24154fd169ea0f55d68ee66a6f287ff8b2fc33c99d37fb1c2ea536.png | complex | <table><tr><td rowspan="2">Semester</td><td colspan="2">Nominees</td><td colspan="2">Non-nominees</td></tr><tr><td>Weekday</td><td>Weekend</td><td>Weekday</td><td>Weekend</td></tr><tr><td>Semester 1</td><td>97</td><td>63</td><td>28</td><td>8</td></tr><tr><td>Semester 2</td><td>303</td><td>144</td><td>42</td><td>13</td>... |
dc1c2e2697d8a986b783526df1d970359d1f2c23e94a93dc09f1ea1da74fcec7.png | complex | <table><tr><td>Variables</td><td colspan="3">CSS</td><td colspan="3">OS</td></tr><tr><td></td><td>HR</td><td>95%CI</td><td><i>p</i>-Value</td><td>HR</td><td>95%CI</td><td><i>p</i>-Value</td></tr><tr><td>Age (continuous variable)</td><td>1.037</td><td>1.027–1.048</td><td><0.001</td><td>1.041</td><td>1.032–... |
9a89d15fa2119ac6b27224eeb6e9483c75bdb255ec1613b4f62c32a8e56e09bb.png | simple | <table><tr><td></td><td>6 months</td><td></td><td></td><td>12 months</td><td></td><td></td></tr><tr><td>Characteristics</td><td>n/N (%)</td><td>RR</td><td>95%CI</td><td>n/N (%)</td><td>RR</td><td>95%CI</td></tr><tr><td>Minority</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>No</td><td>593/627 (9... |
76c5278e63ed469a2097cb31c4ea34308026d985dfe1c7f2829e79b019087f87.png | complex | <table><tr><td></td><td></td><td colspan="3">Age group</td><td></td></tr><tr><td>Baseline characteristic</td><td></td><td>Overall cohort (<i>n</i>=41,088)</td><td>>50 years (<i>n</i>=2591)</td><td>15 to 50 years (<i>n</i>=38,497)</td><td><i>p</i>-value (>50 <i>vs</i> 15 to 50 years)</td></tr><tr><td>Age (years)</... |
44923ae2ab75a413b83f49fbb4c6ea9e33cebce0bb96877e5f1bda69537ce227.png | simple | <table><tr><td>Test</td><td>Strain H-6</td><td><i>Alteromonas macleodii</i></td></tr><tr><td>Starch hydrolysis</td><td>+</td><td>+</td></tr><tr><td>Catalase</td><td>+</td><td>+</td></tr><tr><td>H<sub>2</sub>S production</td><td>+</td><td>+</td></tr><tr><td>Gelatin hydrolysis</td><td>+</td><td>+</td></tr><tr><td>Indole ... |
2e7b4d125b8ec55d99e179d845a6bea6c2c4603f58aec7fdca4247b0a2a40bea.png | simple | <table><tr><td>Polymorphism</td><td>Cachexia <i>n</i> = 61 (%)</td><td>Noncachexia <i>n</i> = 64 (%)</td><td><i>χ</i><sup>2</sup></td><td><i>P</i></td></tr><tr><td>IL-8 −251 A/T</td><td></td><td></td><td>1.224</td><td>.542</td></tr><tr><td> AA</td><td>12 (19.7)</td><td>8 (12.5)</td><td></td><td></td></tr><tr... |
ef5b05697f5e19c0711fc48a08d0ef04b38779d11ca62c34f799929356b1f198.png | complex | <table><tr><td></td><td></td><td colspan="3">2004</td><td colspan="3">2005</td></tr><tr><td></td><td></td><td>dry season</td><td>rainy season</td><td>global</td><td>dry season</td><td>rainy season</td><td>global</td></tr><tr><td>Data</td><td>Mean</td><td>0.390</td><td>0.311</td><td>0.351</td><td>0.166</td><td>0.212</td... |
2e8fb8ef9f6ef4cf9921d42a8b32688b048d8e2b39f2cfec1e4e79966080b920.png | simple | <table><tr><td></td><td>Medical Costs</td><td>Costs per Hypoglycemia Event</td><td>Costs per Cardiovascular Events</td><td>Weight Gain Costs (transition costs<sup>a</sup>)</td><td>Total Costs (without transition costs<sup>a</sup>)</td></tr><tr><td>Metformin monotherapy</td><td>$24</td><td>$0</td><td>$141</td><td>$0</td... |
7098e1b82bd0ed2e256a3e2dc3824aaae86f3d457be52c6e21a92004462fe3a9.png | complex | <table><tr><td>Agricultural sector</td><td>Specific application areas</td><td>References</td></tr><tr><td rowspan="4">Agronomy/Horticulture</td><td>Crop protection</td><td>[2,33]</td></tr><tr><td>Cultivar selection & discrimination</td><td>[34,35,44]</td></tr><tr><td>Pesticide detection</td><td>[33,45–48]</td... |
263d9a1c311d4db0b694cdff451f0da2a579bec326191751ecff62a54767fec6.png | simple | <table><tr><td>Pathways</td><td>Map B</td><td>No. of genes</td><td>No. of TFs</td></tr><tr><td>00010: Glycolysis/gluconeogenesis</td><td>Carbohydrate metabolism</td><td>57</td><td>14</td></tr><tr><td>00500: Starch and sucrose metabolism</td><td>Carbohydrate metabolism</td><td>32</td><td>12</td></tr><tr><td>00520: Amino... |
8a9fe09d2a779fce9004a46e795f714353837202c9f5d8cd6f7082bf00c4e314.png | simple | <table><tr><td>Contig_ID</td><td>Log2_Fold_change</td><td>Adj<i>P</i>_value</td><td>2C FPKM</td><td>2 T FPKM</td><td>E-value</td><td>Protein families</td></tr><tr><td>c32642_g1_i1</td><td>-3.614</td><td>0.0009</td><td>3.1</td><td>0.3</td><td>0</td><td>Glycosyltransferase 8 family, Glycogenin subfamily</td></tr><tr><td>... |
eb65959ecdfbbfb273f674f5e294444d389c79a595fc5c6dd9c49a946ee813ac.png | complex | <table><tr><td></td><td>WC</td><td>BMI</td><td>PBF</td><td>HDL</td><td>Triglyceride</td><td>LDL</td><td>SBP</td><td>DBP</td></tr><tr><td colspan="9">Females</td></tr><tr><td> 8 year old cohort</td><td><.05</td><td><.05</td><td><.05</td><td><.05</td><td><.05</td><td></td><td></td><td></td></tr><tr><td> 11... |
03dbc004996232f1fef9b0497717ad01758a18c5ec0785b081cfd2fc85b9c9ae.png | simple | <table><tr><td>Causes of death</td><td>Number of deathsn (%)</td><td>Cause-Specific Mortality Rate (per 1000 people)</td></tr><tr><td>Ch. X – Diseases of the respiratory system, J00-J99</td><td>282 (37.1)</td><td>3187</td></tr><tr><td>Ch. IX – Diseases of the circulatory system, I00-I99</td><td>197 (25.9)</... |
1cbedbd60043a082d02732ebc507ff1e30733e1e75fc77983773c03603d625e5.png | complex | <table><tr><td rowspan="2">Case</td><td rowspan="2">Measure</td><td colspan="2">Improvement</td><td colspan="2">Execution time</td></tr><tr><td>Standard</td><td>Scout</td><td>Standard</td><td>Scout</td></tr><tr><td rowspan="5">I</td><td>Average</td><td>47.36%</td><td>57.21%</td><td>2.0065</td><td>1.2346</td></tr><tr><t... |
d6653c6ea89f0c13d6a70e69172b2c0cdb9235a686c268a8f4104a8b6766d17c.png | complex | <table><tr><td rowspan="2">Sample ID</td><td colspan="3"><i>AR</i>W742C (TGg>TGt/c)ddPCRNEB Phusion<sup>®</sup> Preamplification</td><td colspan="3"><i>AR</i>W742C (TGg>TGt/c)ddPCRInvitrogenTM PlatinumTM SuperFiTM Preamplification</td></tr><tr><td>Mutant Droplet Count</td><td>Wild-type Droplet Count</td><td>... |
41cd3aa8f4955df3da17f85f92559b0c9db379487dd73fe597ee539ab41b1342.png | simple | <table><tr><td>Line</td><td>Ca (%)</td><td>K (%)</td><td>Mg (%)</td><td>P (%)</td><td>N (%)</td><td>S (%)</td><td>B (mg/kg)</td><td>Cu (mg/kg)</td><td>Fe (mg/kg)</td><td>Mn (mg/kg)</td><td>Mo (mg/kg)</td><td>Na (mg/kg)</td><td>Zn (mg/kg)</td></tr><tr><td>243</td><td>2.2</td><td>1.4</td><td>0.5</td><td>0.2</td><td>1.3</... |
f5452c5811688ef4b1d28afe1d5057ead27c65f3e016fb34fbc32f333ce2704c.png | simple | <table><tr><td>Domain</td><td>Principal cause</td><td>Number of patients</td></tr><tr><td>Neuromuscular</td><td>Parkinsonism syndrome</td><td>3</td></tr><tr><td></td><td>Unexplained Ataxia</td><td>2</td></tr><tr><td></td><td>Lower extremity weakness</td><td>7</td></tr><tr><td>Sensory</td><td>Dizziness or vertigo</td><t... |
5195299103baca653e98863703fc1981f035050e892129a09a792957b283cd71.png | simple | <table><tr><td></td><td>RECIST</td><td>CHOI</td><td>mCHOI</td><td>MASS</td></tr><tr><td>Progressive disease (MASS unfavourable response)</td><td>Increase in sum of longest target lesion diameters >20%.orDevelopment of new lesions.orUnequivocal non-target lesion progression.</td><td>Increase in lesion size<sup>a</sup... |
a4e401b6d61905f718123d62f42dc48d4a26d8dd0ca0342912ca7e8c702113f6.png | complex | <table><tr><td>Indicator bacteria</td><td>Station</td><td>N</td><td>Mean</td><td>Std. Deviation</td><td>Minimum</td><td>Maximum</td></tr><tr><td rowspan="8">Total coliform (MPN/100 ml)</td><td>1</td><td>6</td><td><underline>800</underline></td><td>112.07</td><td>600</td><td>920</td></tr><tr><td>2</td><td>6</td><td>1220... |
1a30a2094c5232554835f1d043c375acb4e16640ae6139e345e5fdb4eda31f2a.png | complex | <table><tr><td rowspan="2">Whole sample size (N = 47)</td><td colspan="4">Placebo</td><td colspan="4">Perilla</td><td>Placebo</td><td>Perilla</td><td> </td></tr><tr><td>Run In</td><td>Intake week 1-2</td><td>Intake week 3-4</td><td>p value (ANOVA)</td><td>Run In</td><td>Intake week 1-2</td><td>Intake week 3-4</td><td>p... |
dba1e653b5941a54727a062fb863b12e5b46552320b3b9568d70f148dff55816.png | complex | <table><tr><td></td><td></td><td></td><td></td><td colspan="5">k-spaced AA pairs</td></tr><tr><td>Feature representation</td><td>Composition Vector</td><td>PSI-BLAST profile</td><td>Binary Encoding</td><td>adjacent pairs (dipeptides)</td><td>1-spaced pairs</td><td>......</td><td><i>p</i>-spaced pairs</td><td>Total</td>... |
4b2c641929eb94e73c79ac608a0ef26ed06c1a09ec5a9ae5eeebac3231a21250.png | simple | <table><tr><td>Haplotype</td><td>Cases (percentage)</td><td>Controls (percentage)</td><td>OR (95% CI)<sup>a</sup></td></tr><tr><td>z1 G-G-T-T-A</td><td>1,250 (49.4)</td><td>1,691 (48.2)</td><td>1.00 (reference)</td></tr><tr><td>z2 G-G-T-C-A</td><td>435 (17.2)</td><td>667 (19.0)</td><td>0.84 (0.72–0.98)</td></tr><... |
995c5316fb3f1f8652c6267ba7e737757d93e5444c93d2e071fa69b50b73f8fd.png | complex | <table><tr><td>Ingredient</td><td>Herb medicine</td><td>Object</td><td>Stimulus</td><td>Role</td><td>related pathway</td></tr><tr><td>1, 6-di-O-caffeoyl-<i>β</i>-D-glucopyranoside</td><td>Callicarpa nudiflora Hook</td><td>Platelet</td><td>ADP, AA</td><td><i>α</i>IIb<i>β</i>3, 5-HT, TXA2, platelet aggrega... |
8919b0d2f6d9a5f24354560b9574a407c4eec65253d16169b9e73b765f56a4a2.png | complex | <table><tr><td></td><td colspan="3">Incremental cost</td><td colspan="3">Incremental effect</td><td rowspan="2">ICER</td></tr><tr><td></td><td colspan="3">Mean; (95% bootstrap CI)</td><td colspan="3">Mean; (95% bootstrap CI)</td></tr><tr><td colspan="8">CBT versus TAU</td></tr><tr><td colspan="2">Completers (<i>N</i>=1... |
d2886a2f51fe8dabe25ed74486238d56d4c960e22726af646ceeab6c0689d0f9.png | simple | <table><tr><td>Flavonoid</td><td>NGF</td><td>GDNF</td><td>BDNF</td></tr><tr><td>Flavanones</td><td> </td><td> </td><td> </td></tr><tr><td> Alpinetin</td><td>+++</td><td>++</td><td>+</td></tr><tr><td> Hesperidin</td><td>—</td><td>+</td><td>—</td></tr><tr><td> Naringenin</td><td>—</td><td>—</td><t... |
f244a13738e3c1266d9bc518abe526108c6543937fdd0e769c2d47c39ae625ba.png | simple | <table><tr><td>Variables</td><td>N</td><td>Case/Control</td><td>OR(95%CI) <i>P</i><sub>h</sub><i>P</i></td><td>OR(95%CI) <i>P</i><sub>h</sub><i>P</i></td><td>OR(95%CI) <i>P</i><sub>h</sub><i>P</i></td><td>OR(95%CI) <i>P</i><sub>h</sub><i>P</i></td><td>OR(95%CI) <i>P</i><sub>h</sub><i>P</i></td></tr><tr><td></td><td></t... |
03bf356684fc6577f87dd54f05604ddf03a414b3c8bddaf93f846e4bf2b228d9.png | simple | <table><tr><td>Gene ID</td><td>ENSEMBL Gene ID</td><td>Gene name</td><td>Base Mean</td><td>Fold Change (log2)</td><td>p-adj</td></tr><tr><td>VIM</td><td>ENSECAG00000004216</td><td>vimentin</td><td>101,873.95</td><td>0.49</td><td>0.0846</td></tr><tr><td>LUM</td><td>ENSECAG00000018248</td><td>lumican</td><td>93,834.08</t... |
579b4bef306c94fe2dcdd892ef0dbeefffe606a648610e055e400e7204f6f632.png | simple | <table><tr><td>Treatment category</td><td></td></tr><tr><td>Cat I</td><td>Treatment for new patients with first-line anti-TB drugs (2 months of INH, RIF, EMB, PZA/4 months of INH, RIF)</td></tr><tr><td>Cat II</td><td>Re-treatment regimen with first-line anti-TB drugs (2 months of STR, INH, RIF, EMB, PZA/1 month of INH,... |
eb1f9d0a9fd94eddcc87ac5bb123c4fbe16e06f0346ec6fe81b6e6048ef544e3.png | complex | <table><tr><td> </td><td> </td><td>PT (n = 21)</td><td>ST (n = 23)</td><td>p value</td></tr><tr><td rowspan="3">Global score</td><td>Baseline</td><td>26.0 ± 11.2</td><td>29.7 ± 9.8</td><td>0.256<sup>†</sup></td></tr><tr><td>After training</td><td>25.7 ± 10.6</td><td>24.5 ± 7.7</td><td>0.678<su... |
b6c956023a70bd9e5bef7aa234cb2623bfe85b79ebfcc90918bc16c12d636018.png | complex | <table><tr><td>Contact Stress, GPa</td><td>Rolling Time, h</td><td>Rolling Speed, rpm</td><td>Condition</td></tr><tr><td>2.5</td><td rowspan="2">12, 24</td><td rowspan="2">1000</td><td rowspan="2">dry</td></tr><tr><td>3.0</td></tr></table> |
577423bcffe69e61a528803a48e1b2c5478bf31124800088f002b17dd4f37a4d.png | simple | <table><tr><td>Effect size</td><td>Point estimatefreqpost mean post median</td><td>Percentile bootstrap</td><td>Bias-corrected bootstrap</td><td>Bayesian equal-tail credibilityintervals</td><td>Bayesian HPD credibilityintervals</td></tr><tr><td>Med<sub>ps</sub></td><td>0.1080.1050.106</td><td>[0.059, 0.183]</td><td>[0.... |
c19abd2abfd3ff265a1c085257fed604b47910c81521337bfc56b64a61814b78.png | complex | <table><tr><td rowspan="2" colspan="2">Segmental LV wall</td><td colspan="3">Endocardial (%)</td><td colspan="3">Middle (%)</td><td colspan="3">Epicardial (%)</td></tr><tr><td>Preoperative</td><td>Postoperative</td><td><i>P</i>-value</td><td>Preoperative</td><td>Postoperative</td><td><i>P</i>-value</td><td>Preoperative... |
b45eaddb81098559714d0e9c59b4e87a1070b1c140bea0768bb9a2d3a373e3f4.png | simple | <table><tr><td></td><td>Screening</td><td>Randomization</td><td>3 monthlyFU</td><td>6 monthlyFU</td><td>End of study</td></tr><tr><td>25(OH)D3 serum levels</td><td></td><td>X</td><td>X(when 25(OH)D3 levels >80 ng/ml and study drug temporarily interrupted)</td><td>X</td><td></td></tr><tr><td>Blood sample for DNA anal... |
6bc4078bb568e579a62fcaf19f47a15c93d6bf8e74d5ad57c652b4102db75973.png | simple | <table><tr><td>Author, date</td><td>No. Participants = n</td><td>Avg age at start</td><td>Cast changed</td><td>Avg days in casts - ‘fast’ group</td><td>Tenotomy rate</td><td>Follow up</td><td>Comment</td></tr><tr><td>Morecuende, 2005</td><td>230(non-random)</td><td>Not stated</td><td>5 days</td><td>30</td><... |
5d239577ca52c29740b32cbe741ce8b0d43c78b8dc8f05061d2aa350360b93de.png | simple | <table><tr><td>Variable</td><td>Coefficient</td><td>S.E.</td><td>p-value</td><td>OR</td><td>95%CI</td></tr><tr><td>Intercept</td><td>-5.21</td><td>4.44</td><td>-</td><td>-</td><td>-</td></tr><tr><td>Mains water to the farmhouse</td><td>-8.56</td><td>1.25</td><td>< 0.0001</td><td>0.0002</td><td>1.64E<sup>-5 </sup>: 2... |
1b4d543aa8f5609d7a0b6a6c86ab39ee3ec600b02765af9d34548cb7cd7a4dbf.png | complex | <table><tr><td></td><td colspan="3">Bacteria</td><td colspan="3">Methanogens</td></tr><tr><td>Community</td><td>Similarity</td><td>Pseudo- <i>F</i></td><td><i>P-</i>value</td><td>Similarity</td><td>Pseudo- <i>F</i></td><td><i>P-</i>value</td></tr><tr><td>Treatment effect</td><td></td><td>4.54</td><td>0.007</td><td></td... |
58ff983adbc67fe6ad39e756680513b34cd2b3745028b306eb975b11407583a0.png | simple | <table><tr><td>Code Level 3</td><td>Label level 3</td><td>Assigned land use type</td></tr><tr><td>111</td><td>Continuous urban fabric</td><td>Urban</td></tr><tr><td>112</td><td>Discontinuous urban fabric</td><td>Urban</td></tr><tr><td>121</td><td>Industrial or commercial units</td><td>Urban</td></tr><tr><td>122</td><td... |
b1c4c1ca3a7dc812da54a86e8bf40c24687b53b53274b40f1e83741b64b586c5.png | simple | <table><tr><td>Variables</td><td>Crude ORs</td><td>Model 1</td><td>Model 2</td><td>Model 3</td></tr><tr><td>Older Ages: Age ≥ 80</td><td>1.74 (1.28, 2.36) *</td><td>1.29 (0.93, 1.80)</td><td></td><td>1.26 (0.91, 1.75)</td></tr><tr><td>Living Alone</td><td>1.66 (1.26, 2.19) *</td><td>1.27 (0.91, 1.78)</td><td></td... |
759f138e626de5d09726e5aa71a7e9cb0a73d9631fe755793c11dee09c1a6be6.png | simple | <table><tr><td><i>Function</i></td><td><i>P-value</i></td><td><i>No. of Genes</i></td></tr><tr><td>Cellular movement</td><td>2.10E-35 to 3.60E-05</td><td>584</td></tr><tr><td>Cell death</td><td>1.99E-30 to 3.56E-05</td><td>853</td></tr><tr><td>Cellular development</td><td>2.08E-29 to 3.43E-05</td><td>730</td></tr><tr><... |
1e7acbb1731e2adf341b4bd00b4aa549b184ca1ae4ff3395ed982ea25e06ba92.png | simple | <table><tr><td>Food Groups</td><td>Factor I Meat–Instant Food Dietary Pattern</td><td>Factor II Vege–Seafood Dietary Pattern</td><td>Factor III Cereal–Dairy Dietary Pattern</td></tr><tr><td>Milk</td><td>−0.174</td><td>0.047</td><td>0.597</td></tr><tr><td>Dairy products</td><td>0.038</td><td>0.05... |
e1fa0426ea424643bbf84610bbceba4030cf407823b52df73b07bc80fc73ab92.png | complex | <table><tr><td rowspan="2">Algorithm</td><td rowspan="2">TP (%)</td><td rowspan="2">FN (%)</td><td rowspan="2">FP (%)</td><td rowspan="2">SE (%)</td><td rowspan="2">+P (%)</td><td colspan="3">Threshold values</td></tr><tr><td>THR<sub>1</sub></td><td>THR<sub>2</sub></td><td>THR<sub>3</sub></td></tr><tr><td>Proposed</td>... |
d722f7edce3ef4b88381cfaca3b7b6c41098530209783c41c5a14e1f8d0f0f38.png | simple | <table><tr><td></td><td>Cases</td><td>sCD157 <31.02 ng/ml</td><td>sCD157 ≥31.02 ng/ml</td><td><i>P</i> value<sup>*</sup></td></tr><tr><td>MPM, <i>n</i></td><td>61</td><td>30</td><td>31</td><td></td></tr><tr><td>Age at diagnosis, y</td><td></td><td></td><td></td><td>0.062</td></tr><tr><td> mean ± SD</td><t... |
6a1cf9a23b9a956d1edaa89f6d2ff935f1a3a9393f3f1e54ddb026563b77a056.png | simple | <table><tr><td>Partition number</td><td>Cluster number</td><td>BRCA1</td><td>BRCA2</td><td>Number of genes selected</td></tr><tr><td>1</td><td>1</td><td>0</td><td>4</td><td>80</td></tr><tr><td></td><td>2</td><td>7</td><td>4</td><td></td></tr><tr><td>2</td><td>1</td><td>7</td><td>4</td><td>110</td></tr><tr><td></td><td>... |
7ece8b867bb765050e160706db5dc5a97ac65b2451d1fed44bd50bb921ea32b7.png | complex | <table><tr><td>miRNA name</td><td>PTC</td><td><i>N</i></td><td><i>P</i>‐value</td><td>Fold change</td></tr><tr><td colspan="5">Upregulated</td></tr><tr><td>miR‐221‐5p</td><td>10.35 ± 3.68</td><td>2.88 ± 1.15</td><td><0.001</td><td>3.91 ± 1.36</td></tr><tr><td>miR‐222‐5p</... |
ab6c1a3f6dd1099970c1375d9962fb4fecc214d6a6e3412966e44425bb1a2e14.png | complex | <table><tr><td> </td><td> </td><td colspan="2">Single methods</td><td colspan="2">Combined method</td></tr><tr><td>Case</td><td>Histology (Lauren)</td><td>IHC (Score)</td><td>SISH (≥ 2.0/< 2.0)</td><td>IHC (Score)</td><td>SISH (≥ 2.0/< 2.0)</td></tr><tr><td>6693</td><td>i</td><td>2+</td><td>≥2.0... |
d5106327c9e794a372e1442bf19ff047dd865b186c7451a373f984fdcbfdffbd.png | simple | <table><tr><td></td><td>pN0 and pN1</td><td>pN2 and pN3</td><td>p-value</td></tr><tr><td>Percentage of positive tumors cells</td><td>47.12 +/- 29,.3</td><td>55.62 +/- 26.33</td><td>0.068</td></tr><tr><td>Staining intensity</td><td>1.22 +/- 0.82</td><td>1.43 +/- 0.75</td><td>0.036*</td></tr></table> |
2ed7ec51ddee38fffe932db400d99e888a461187fb08bb1477213521983e43b4.png | complex | <table><tr><td>Variables</td><td>Name and source of the original scales and items</td><td>α</td><td>Items (n)</td></tr><tr><td colspan="2">Socio-demographic factors<sup>a</sup></td><td></td><td>18</td></tr><tr><td colspan="4">Health behaviour</td></tr><tr><td> Physical activity</td><td>Health Questionnaire age 18&... |
ad64da938345c664ba760f7645ce1b64bf0fa316feae1ebdb38a22e752d55f9f.png | simple | <table><tr><td></td><td>Coefficient</td><td>Standard Error</td><td>P-value</td></tr><tr><td>HIV-infected</td><td></td><td></td><td></td></tr><tr><td><i>For Log IP-10</i></td><td></td><td></td><td></td></tr><tr><td>Gender</td><td>0.153</td><td>0.101</td><td>0.131</td></tr><tr><td>Age</td><td>0.005</td><td>0.005</td><td>... |
b8bca159ec31bc6bd1b1eae81e686b33000a96785167a6c01921ae8dcc97e795.png | complex | <table><tr><td>PROCEDURE</td><td colspan="3">ONCOLOGIC RESULTS</td></tr><tr><td>RARC<sup>*</sup></td><td>equivalent lymph node yields</td><td>comparable overall and recurrence-free survival</td><td>similar positive surgical margins in ≤ T2 disease</td></tr><tr><td>RAPN<sup>§</sup></td><td>comparable margin s... |
62ff4cfbefe39b414c04a56a971c531fbbabb20608106ea2578ecc6c6a4b7f3c.png | complex | <table><tr><td>Comorbidity</td><td colspan="2">ICD codes</td></tr><tr><td rowspan="2">Heart failure</td><td>ICD-8:</td><td>427, 428</td></tr><tr><td>ICD-10:</td><td>I42, I50, I110, J819</td></tr><tr><td rowspan="2">Ischaemic heart disease</td><td>ICD-8:</td><td>411, 412, 413, 414</td></tr><tr><td>ICD-10:</td><td>I20, I... |
83f7247e9fe57e12446d290b1544908826ba480a591d5575eeede8c4c3c29425.png | complex | <table><tr><td>Group Examined (ICD-9 Code)</td><td>0 μg Organic-Hg (%) (Reference Dose)</td><td>12.5 μg Organic-Hg (%)</td><td>25 μg Organic-Hg (%)</td><td>37.5 μg Organic-Hg (%)</td><td>Odds Ratio per μg Organic-Hg (95% CI) (<i>p</i>-value)</td></tr><tr><td>Febrile Seizure Cases (780.3)</td><t... |
aea29679a7f78a0271bd9a0ee8e68c7027187d90f7adb27a687422dbc9bec239.png | simple | <table><tr><td>Advantages</td><td>Shortcomings</td></tr><tr><td>Available anywhere on the earth in any weather conditions for outdoor measurements at no cost</td><td>High cost of professional equipment</td></tr><tr><td>Tri-dimensional positioning with centimeter accuracy (Real Time Kinematics, RTK mode)</td><td>Not ful... |
341d8314d66005f289ad2f64151b8d29628277bbc82d426f478893cb611471aa.png | complex | <table><tr><td colspan="4">Operation (Pipette-dependence mode<sup>a</sup>)</td><td>Purpose</td><td>Details</td></tr><tr><td rowspan="9">PF</td><td>1</td><td colspan="2">Input (I-mode)</td><td>Liquid charging into MMV wells</td><td>Figure 1c</td></tr><tr><td rowspan="2">2</td><td rowspan="2">Output (O-mode)</td><td>a. T... |
d9a5e0918cbf7ff712a32358fea707e0b238b2558a9e35e158036d2411c375dd.png | complex | <table><tr><td>Gene</td><td>Sequence (5′-3′)</td><td>Product size (bp)</td></tr><tr><td rowspan="2">IL-6</td><td>For: CCTGACCCAACCACAAATGC</td><td rowspan="2">646</td></tr><tr><td>Rev: CCTTAAAGCTGCGCAGAATGA</td></tr><tr><td rowspan="2">IL-8</td><td>For: CTTTCCACCCCAAATTTATCAAAG</td><td rowspan="2">264</td><... |
17e11fed2b13ed3288c35e659a7583d6fcd4d4ccd6ec1929b4c254d7f1d4deb7.png | complex | <table><tr><td></td><td colspan="2">Before SS exposure on PND59</td><td colspan="2">After SS exposure on PND59</td></tr><tr><td>Group</td><td>R<sub>L</sub></td><td>C<sub>dyn</sub></td><td>R<sub>L</sub></td><td>C<sub>dyn</sub></td></tr><tr><td>GD7 SS</td><td>1.12 ± 0.11</td><td>0.053 ± 0.014</td><td>1.18 ±... |
01e42bd2b7f572b8c71342529844a1ffed76cca443130bf44304d53caa99445b.png | complex | <table><tr><td></td><td colspan="2">EAPs for sensing</td></tr><tr><td></td><td>pros</td><td>cons</td></tr><tr><td colspan="3">ionic EAPs</td></tr><tr><td> conducting polymers</td><td>chemical stability, miniaturization, facile fabrication process, low-cost, low-weight, biocompatibility, soft, multiformable (sheet, film... |
17ee5e64ae19261937a50d51eb28461e52cb12cea97790cd67571e6e87e21394.png | simple | <table><tr><td>Model</td><td>Regression coefficient</td><td>[95% CI]</td><td>p</td></tr><tr><td>Intercept</td><td>-17.15</td><td>[-18.94;-14.86]</td><td>-</td></tr><tr><td>Distance</td><td>-3.21</td><td>[-6.17;-1.74]</td><td>0.021</td></tr><tr><td>Biotope</td><td></td><td></td><td></td></tr><tr><td> Clear water</td><td... |
583e4dc493b8cad30bb2e19fe01c8ab94ef34b927c0067fcb8249435477d9cf6.png | simple | <table><tr><td>Drug resistant plasmid Name</td><td>Antimicrobial drug</td><td>Drug resistance plasmid MIC (ug/ml)</td><td>Empty vector MIC (ug/ml)</td><td>Fold increase</td></tr><tr><td>pAMP</td><td>ampicillin</td><td>16</td><td>4</td><td>4</td></tr><tr><td>pAMP</td><td>piperacillin</td><td>3</td><td>2</td><td>1.5</td>... |
0af6ac92797bf484b2eeb99dcb76ff8c208d1f13662116302e8c979d65f9ce8b.png | simple | <table><tr><td>Primers</td><td>Sequences</td><td>Denaturation</td><td>annealing</td><td>Cycles</td><td>PCR products</td></tr><tr><td>HGF: ForwardReverse</td><td>5'-CAGAGGGACAAAGGAAAAGAA-3'5'-GCAAGTGAATGGAAGTCCTTTA-3'</td><td>94°C, 15s</td><td>58°C, 60s</td><td>40</td><td>167 bp</td></tr><tr><td>KGF: ForwardRe... |
916c4afe7cc2fe866bdeab009fc832d9ebe97987e8b072063b6f9ba766f4a6e6.png | simple | <table><tr><td>Base value</td><td>Esmolol group (<i>n</i> = 75)</td><td>Control group (<i>n</i> = 76)</td><td><i>t</i>/<i>χ</i><sup>2</sup></td><td><i>P</i></td></tr><tr><td>Male, <i>n</i> (%)</td><td>54 (72.0)</td><td>53 (69.7)</td><td>0.094</td><td>0.760</td></tr><tr><td>APACHE-II score, mean ± standard dev... |
96066addda506f321b3cce3a8d1f24f25a0c9a5bddc4af3e43aba42e481b57dd.png | complex | <table><tr><td rowspan="2" colspan="2"></td><td colspan="2">Inter-rater</td><td colspan="2">Intra-rater</td></tr><tr><td>FT</td><td>ROl</td><td>FT</td><td>ROl</td></tr><tr><td>L4 (N=103)</td><td>FA R/L</td><td>0.89/0.89</td><td>0.68/0.54</td><td>0.79/0.83</td><td>0.78/0.78</td></tr><tr><td></td><td>ADC R/L</td><td>0.96... |
ba440d9d0cc415c4101267033e91fa9f641207821f8d479e03dc1291468a54b9.png | complex | <table><tr><td>Virus</td><td>Dilution</td><td>Virus isolation</td><td>Real time RT-PCR</td><td>CT</td></tr><tr><td>WEEV</td><td>10<sup>-1</sup></td><td>4/4</td><td>+</td><td>15.25</td></tr><tr><td></td><td>10<sup>-2</sup></td><td>4/4</td><td>+</td><td>18.29</td></tr><tr><td></td><td>10<sup>-3</sup></td><td>4/4</td><td>... |
a499781545d1e08bff4367e036f9f19f8a913b7eae6829ca739bd0cf484aaca6.png | simple | <table><tr><td><i>True/False item</i></td><td>Correct answer</td><td>% correct*</td><td><i>True/False item</i></td><td>Correct answer</td><td>% correct*</td></tr><tr><td>HIV/AIDS KNOWLEDGE</td><td> </td><td> </td><td>OVERDOSE KNOWLEDGE</td><td> </td><td> </td></tr><tr><td>When a couple decides that they are ONLY going ... |
996ad56d35aed35bda33b893ec65fd18a510690a4a7621355d17429df7ddeba7.png | simple | <table><tr><td>Productivity software</td><td>Microsoft Office</td></tr><tr><td></td><td>Endnote</td></tr><tr><td></td><td>Toolbook Runtime (with modules)</td></tr><tr><td>Medical Software (Anatomy)</td><td>A.D.A.M</td></tr><tr><td></td><td>Anatomy TV</td></tr><tr><td></td><td>Grant's Atlas of Dynamic Human Anatomy</td>... |
a314401b28b8ce768194f9f9c96c217f5451a17fdb4bb73f5c3662df58c60b65.png | simple | <table><tr><td>Number</td><td>Scenario</td></tr><tr><td>1</td><td>Human papilloma virus positive state</td></tr><tr><td>2</td><td>Cervical intraepithelial neoplasia grade I</td></tr><tr><td>3</td><td>Cervical intraepithelial neoplasia grade II/III</td></tr><tr><td>4</td><td>Cervical cancer requiring simple or radical h... |
3d10f0c41b2a452e881f2860f12bf80a5640c8d66c02e7f38eb72006e26a2159.png | complex | <table><tr><td><i>District</i></td><td><i>Locality (n)</i></td><td><i>Seroprevalence % (proportion)</i></td><td><i>95% C.I.</i></td><td><i>P-value</i></td></tr><tr><td rowspan="5">Charsadda</td><td>Ataki (38)</td><td>36.8 (14/38)</td><td>21.8–54.0</td><td>Χ<sup>2</sup> = 7.63</td></tr><tr><td>Batagram (29)</... |
eaf67a2fc851b5f596eb04d94dee3bd02e943e0004be7245213b5fae5c5deebf.png | complex | <table><tr><td>Parameter</td><td>HMA All Lines (<i>n</i> = 88)</td><td>First-Line HMA (<i>n</i> = 41)</td><td>First-Line ICT (<i>n</i> = 122)</td><td><i>p</i>-Value First-Line HMA vs. ICT</td></tr><tr><td>Median age at diagnosis, years</td><td>69</td><td>73</td><td>60</td><td>0.1698</td></tr><tr><td> (min–max)</t... |
407a1fce2a86dcb140851f5bb8e67804dc21f8b1573b3f580f5ec708229d93cd.png | simple | <table><tr><td>Molecular Category</td><td>TGFβ Sub-Family Pathway <sup>1</sup></td><td>BMP Sub-Family Pathway</td></tr><tr><td>Ligands</td><td>TGFβs, ActivinsGDF8/9/10/11, BMP3, Nodal</td><td>BMP2/4/5/6/7/8/9/10, GDF1/3/5/6/7, MIS</td></tr><tr><td>Type II receptors</td><td>TβRII, ActRIIA, ActRIIB</td><td... |
79c450f12d952e2df231274683ff81dd4fde3063b8609099e96092e76bd1f4e6.png | simple | <table><tr><td>Comparison</td><td>p value</td><td>r value</td></tr><tr><td>Quads Strength and TWT</td><td></td><td></td></tr><tr><td>Baseline</td><td>0.003</td><td>-0.688</td></tr><tr><td>Week 6</td><td>0.003</td><td>-0.697</td></tr><tr><td>Week 12</td><td>0.005</td><td>-0.662</td></tr><tr><td>Quads Strength and TST</t... |
6a87d352059f4e7569e8b77f376ad59b2ff6fa097a9eecf6122149e645d4ad7b.png | complex | <table><tr><td></td><td colspan="2">FMF</td><td></td></tr><tr><td></td><td>Rheumatic diseases (+)</td><td>Rheumatic diseases (–)</td><td></td></tr><tr><td></td><td><i>n</i> = 26</td><td><i>n</i> = 166</td><td><i>p</i></td></tr><tr><td>Male/female</td><td>4/22</td><td>79/87</td><td>0.002</td></tr><tr><td>Age at on... |
61850dd9c42f586607c810f443ff7ca086c53e94cd36a6f9e546936de94b7340.png | simple | <table><tr><td>MicroRNA</td><td>Location</td><td>Model</td><td>Response</td><td>References</td></tr><tr><td>miR-200c</td><td>Upstream</td><td><i>db</i>/<i>db</i> T2DM</td><td>Increase aorta endothelial dysfunction</td><td>[101]</td></tr><tr><td>miR-320</td><td>Upstream</td><td>High glucose treated HUVECs</td><td>Reduce... |
00a8c9cba53e2b1eed21f546c8e9ba19a6213b782b86b3aaff31614d58038a6b.png | complex | <table><tr><td></td><td></td><td>Uncorrected T<sub>2</sub>Prep‐IR BOOST</td><td>Motion Corrected T<sub>2</sub>Prep‐IR BOOST</td><td></td></tr><tr><td rowspan="3">RCA</td><td>Length (cm)</td><td>7.03 ± 1.50</td><td>8.58 ± 2.27</td><td><i>P</i> < 0.02</td></tr><tr><td>%VS (4 cm)</td><td>36.54 ... |
07340370d126b78e2563e72ff0941560d3ded39cdafaf90cd73774d677828fef.png | simple | <table><tr><td>Site/size</td><td>Mean</td><td>StDev</td><td>Min</td><td>Med</td><td>Max</td></tr><tr><td>EF >100</td><td>0.02615</td><td>0.02849</td><td>0</td><td>0.0159</td><td>0.10568</td></tr><tr><td>EF >50 < 100</td><td>1.02039</td><td>0.02286</td><td>0</td><td>0.01761</td><td>0.07789</td></tr><tr><td>EF &... |
0a66f313c94e7f3a03368923c37332c871bdffc0f4135add86d2301ea0580a4b.png | complex | <table><tr><td> </td><td colspan="5"><i>Expression in A549</i></td></tr><tr><td> </td><td><i>Parental (fold)</i></td><td><i>Senescent RNA-seq (fold)</i></td><td><i>Senescent RT-PCR (fold)</i></td><td><i>Revertant RNA-seq (fold)</i></td><td><i>Revertant RT-PCR (fold)</i></td></tr><tr><td>NPTX1</td><td>1</td><td>23</td><... |
0fbb76c05311a2649001250f59f9d69fb5c577d1d8176d0dafeb172d2dd0fe69.png | complex | <table><tr><td>Cheese sample</td><td>Area assessed</td><td><i>a</i> value at 144 days</td></tr><tr><td rowspan="4">Control</td><td>Top</td><td>−2.22</td></tr><tr><td>Side</td><td>−2.17</td></tr><tr><td>Base</td><td>−2.32</td></tr><tr><td>Center</td><td>−2.38</td></tr><tr><td rowspan="4">Exp1</td... |
0906d2635be23c4a54c7dc593ba6e8244ca9d787d370f2c7f3800a2757cdcbe6.png | simple | <table><tr><td></td><td>Low Rate </td><td>Medium Rate </td><td>High Rate </td><td><i>p</i>-value </td></tr><tr><td>Countries with implemented screening programmes</td><td>22% (2/9)</td><td>67% (6/9)</td><td>89% (8/9)</td><td>0.014</td></tr><tr><td>Countries with guidelines for screening</td><td>11% (1/9)</td><td>78% (7... |
2a48d7da3e0bdf648a3d89310f3b4fa1a604001ca2c9c3e47fca6b7bcd891e36.png | complex | <table><tr><td></td><td colspan="4">Reported obstetric complications or near misses</td></tr><tr><td>Independent variables</td><td>Eclampsia</td><td>Hemorrhage</td><td>Sepsis</td><td>Obstructed labor</td></tr><tr><td></td><td>(n = 324)</td><td>(n = 4,945)</td><td>(n = 3,120)</td><td>(n = 2,847)</td></tr><tr><td></td><t... |
98db322d9ee49e419b1986da46dfde27a8e2a7c329a0bf9f9c8e6a5081d809bd.png | complex | <table><tr><td></td><td colspan="3">Swollen joints</td><td colspan="3">Tender joints</td></tr><tr><td></td><td>32JC<sup>- </sup>(<i>n </i>= 760)</td><td>28JC<sup>-</sup>/32JC<sup>+ </sup>(<i>n </i>= 38)</td><td><i>p</i></td><td>32JC<sup>- </sup>(<i>n </i>= 1,120)</td><td>28JC<sup>-</sup>/32JC<sup>+ </sup>(<i>n </i>= 10... |
37dd042ad11ecbeba4c91c206ebc5e7228e187ae5998c9e0e52ce989593357eb.png | simple | <table><tr><td>Outcome variable</td><td>ESeC 1</td><td>ESeC 2</td><td>ESeC 3</td><td><i>p</i></td></tr><tr><td><i>ESS score</i></td><td>9.24±5.27</td><td>9.41±4.9</td><td>8.92±5.2</td><td>0.645</td></tr><tr><td>Median (IQR)</td><td>8.5 (5-12)</td><td>9 (6-13)</td><td>8 (5-12)</td><td> </td></tr><tr><td>M... |
da78433fd3322fe3e3335de7bb841d0786ad983fb3c78827e0f4ac1161a1365b.png | simple | <table><tr><td>Supernatant conditions</td><td>Protein concentration (mg/mL)</td><td>Degradation (%)</td></tr><tr><td>Culture supernatant</td><td>0.24 ± 0.03</td><td>50.48 ± 2.40</td></tr><tr><td>Super filtered culture supernatant <sup>a</sup></td><td>1.22 ± 0.04</td><td>73.84 ± 1.65</td></tr><tr><td... |
f95ca1498fb99ac14c0635563c95327023f42977fdce7d887fa03b56a3d87b53.png | complex | <table><tr><td rowspan="2" colspan="2"></td><td>Full follow-up scenario</td><td>Early mortality scenario</td></tr><tr><td colspan="2"><i>....Hazard ratio (95 % CI)...</i></td></tr><tr><td rowspan="2">cART</td><td>Yes</td><td>0 · 41 (0 · 18, 0 · 92)</td><td>0 · 28 (0 · 16, 0 · 49)</td></tr>... |
be94fe517d2545ede17dcfe9550b53b17f8b9687c2f73055b4833ca5dd2a06bc.png | simple | <table><tr><td>Variables</td><td>AEP monitor group (<i>n</i>= 19)</td><td>RSS monitor group (<i>n</i>= 18)</td><td>P</td></tr><tr><td>Median number of propofol dosage adjustment</td><td>6 [5-7]</td><td>3 [2-3.8]</td><td><0.001</td></tr><tr><td>Time to the first adjustment of the propofol dosage (second)</td><td>137 ... |
86d69f7f6003d33f7aca5cb1c858f7a268e919a76c310ecb22df73828b9a44d6.png | simple | <table><tr><td>Total (<i>n</i> = 1998)</td><td>ORN/CIT</td><td>PRO/CIT</td><td>ORN/ARG</td><td>Arginine Bioavailability <sup>§</sup></td></tr><tr><td>TG (mg/dL) <sup>φ</sup></td><td>0.062 *</td><td>0.149</td><td>0.027 *</td><td>−0.026</td></tr><tr><td>HDLC (mg/dL) <sup>φ</sup></td><td>−0.051 ... |
dd247bc57f8c795756f38da19ec2f80c6223950b50a2095e105356a92a596395.png | simple | <table><tr><td>Background characteristics</td><td>Total %</td></tr><tr><td>Total 85 participants</td><td> </td></tr><tr><td>Age in years</td><td> </td></tr><tr><td>≥20</td><td>7.7</td></tr><tr><td>21-30 yrs</td><td>37.2</td></tr><tr><td>31-40 yrs</td><td>14.1</td></tr><tr><td>41-50 yrs</td><td>9</td></tr><tr><td>... |
6d6ea4201d4d9ff57d1f4e4fa5c7f738cc0de2e32521a459d1fede5168399e9e.png | complex | <table><tr><td colspan="5">SNP</td><td colspan="3">Gene</td><td colspan="2">SNP vs. IC50</td><td colspan="2">SNP vs. Expression</td><td colspan="2">Expression vs. IC50</td></tr><tr><td> rsID</td><td>Chr</td><td>Position</td><td>Region</td><td>MAF</td><td> Probeset</td><td>Gene symbol</td><td> Chr</td><td>R value</td><t... |
8dc01a8ac6b2e910d71a65335cb5273056db47b126d2ea3be971d832d786c016.png | complex | <table><tr><td>Treatment</td><td colspan="6">Target:Control Ratio</td></tr><tr><td></td><td colspan="3">24 Hour</td><td colspan="3">48 Hour</td></tr><tr><td></td><td>MT1-MMP ± SEM</td><td>MMP-11 ± SEM</td><td>18S rRNA ± SEM</td><td>MT1-MMP ± SEM</td><td>MMP-11 ± SEM</td><td>18S rRNA ± SEM<... |
3dfc596b5f0998e2d2ba56ab77f1382711614f3baee8bc08e3dffd82afadfff3.png | simple | <table><tr><td>Indicator</td><td>Mean 1</td><td>Mean 2</td><td>SD 1</td><td>SD 2</td><td> </td><td><i>p</i></td><td>Error</td></tr><tr><td>1</td><td>15.38 mm</td><td>15.59 mm</td><td>7.52</td><td>7.51</td><td>−0.94</td><td>0.34</td><td>0.97</td></tr><tr><td>2</td><td>60.95 mm</td><td>60.71 mm</td><td>7.69</td><td... |
57637f7bcd960abe42622e2dff3b520f12cbf170dfdfee67298007b032abb3f7.png | complex | <table><tr><td rowspan="2"> </td><td colspan="3"> GD</td><td colspan="3"> HT</td></tr><tr><td>Tx (<i>n</i> = 28)</td><td>Ct (<i>n</i> = 16)</td><td><i>P</i> value</td><td>Tx (<i>n</i> = 39)</td><td>Ct (<i>n</i> = 17)</td><td><i>P</i> value</td></tr><tr><td>Age (year)</td><td>36.2 ± 14.19</td><td>37.24 ± 10.26... |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.